FDA’s ‘key man’ Peter Marks is out. Biotech investors will now deal with the consequences

RFK Jr. says measles vaccine routinely causes deaths. That's not true

Live updates: Marty Makary, Trump’s pick for FDA commissioner, testifies before Senate panel

How to eliminate biotech zombies: Buy them

Pfizer CEO Albert Bourla inflicts injury on his company — and all of pharma

Trump administration rehires some FDA employees it fired

FDA’s former top food official says Trump firings are ‘dismantling’ the division

Biogen partners with Stoke Therapeutics on drug for severe epilepsy

Duchenne gene therapy from Solid Biosciences produces promising results in early study

Drug inspectors, AI experts, maternal health workers: Trump’s health agency cuts are far-reaching

Trump administration lays off FDA employees

CDC cuts expected to devastate Epidemic Intelligence Service, a ‘crown jewel’ of public health

Trump administration to fire thousands at health agencies

Biotech is in a dark place

Two biotechs say they're using AI to conjure drugs from scratch. Their documents suggest otherwise

The CRISPR companies are not OK

Remembering a remarkable Duchenne champion

Personalized cancer vaccine shows potential in kidney cancer

Here is how we know that vaccines do not cause autism

Vertex wins FDA approval for non-opioid pain drug, setting stage for closely watched rollout

The 7 big topics RFK Jr. addressed during a fiery confirmation hearing

Enhertu approved in the US as first HER2-directed therapy for patients with HER2-low or HER2-ultralow metastatic breast cancer following disease progression after one or more endocrine therapies

Akero drug reverses liver scarring in study of severe MASH patients

FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing for the Treatment of Early Alzheimer's Disease

Are you affected by the Trump administration’s pause on health communications, science meetings, and reviews?

FDA purges material on clinical trial diversity from its site, showing stakes of Trump DEI ban

Patrizia Cavazzoni, head of FDA’s drug center, to leave the agency

Another 'JPM Week' nears: Here's my roadmap for biotech's annual SF gathering

The biotech scorecard for the first quarter: 16 stock-moving events to watch

Vertex touts pain drug results, but medicine does not outperform placebo in sciatica study

Worst Biopharma CEO of 2024? It's no contest

Republicans show no signs of blocking Trump’s health secretary pick RFK Jr. so far

Who stood out as Best Biopharma CEO of 2024?

Arcellx won the battle of BCMA CAR-T therapies

Investors in Padlock Therapeutics sue Bristol Myers Squibb over ‘milestone’ payments